Distinguished Speaker Seminars
Please note: Registration is free. Remember to check “autosubscribe” when registering to automatically sign up for future seminars. Also, please bookmark our website to check for future speakers. Important: For the best viewing experience, Google Chrome is the recommended browser. Firefox and Safari also will work. Recordings of recent seminars are posted below.
Jan. 21, 2021 - 11 a.m. EST - Ronald T. Hay, Ph. D., Centre for Gene Regulation and Expression, University of Dundee
"Molecular basis of arsenic treatment for acute promyelocytic leukaemia"
Prof. Hay earned degree in biochemistry at Heriot-Watt University, Edinburgh (1971-1975). He studied for his Ph.D. at the Medical Research Council Virology Unit in Glasgow, working on replication of herpes simplex virus DNA (1975-1979). A Damon Runyon-Walter Winchell Cancer Fund postdoctoral fellowship award allowed him to work in the laboratory of Dr. Mel DePamphilis at Harvard Medical School, where he determined the location and structure of RNA primers that initiate DNA replication at the Simian Virus 40 origin of replication. Prof. Hay moved to the University of St. Andrews and became Chair in Molecular Biology and Deputy Director of the Centre for Biomolecular Sciences. In 2005, he became Chair of Molecular Biology in the University of Dundee and is part of the Centre for Gene Regulation and Expression. Prof. Hay’s research has established conjugation with the Small Ubiquitin-like Modifier (SUMO) as an important regulatory mechanism in eukaryotes. A key role for SUMO and ubiquitin was uncovered in mediating the effects of arsenic when it is used therapeutically in the treatment of Acute Promyelocytic Leukaemia. Recently determination of the structure of a RING E3 ligase and ubiquitin-loaded E2 complex primed for catalysis has revealed the mechanism of ubiquitin modification. Prof. Hay is a Wellcome Trust Senior Investigator and a fellow of the Royal Society, the Royal Society of Edinburgh, the Academy of Medical Sciences, Academia Europaea and is a member of the European Molecular Biology Organisation. In 2012 he was awarded the Novartis Medal and Prize of the Biochemical Society.
Feb. 4, 2021 - 11 a.m. EST - Aleem Siddiqui, Ph.D.
Division of Infectious Diseases and Global Public Health, University of California, San Diego
"Regulation of HBV/HCV infection by N6-methyladenosine modification"
April 30, 2021 - 9 a.m. EDT - Wenhui Li, Ph.D.
Investigator, National Institute of Biological Sciences (NIBS) Beijing, China
2021 Blumberg Prize Recipient
RECENT SEMINARS
Jan. 14, 2021 - Emilio A. Emini, Ph.D., FCPP, FAAM, Director TB and HIV Program Bill & Melinda Gates Foundation
"Controlling the Global HIV and TB Epidemics: Challenges and Opportunities"
Co-hosted by the Pennsylvania Drug Discovery Institute
A recording is posted here.
Dec. 10, 2020 - Dongfang Liu, MBBS, Ph.D, Professor of Pathology, Rutgers N.J. School of Medicine
"Natural Killer (NK) cells from basic immunobiology to clinical application"
A recording is posted here.
Dec. 3 - Stephan Urban, Ph.D., Department of Infectious Diseases, Heidelberg University Hospital
"Inhibitor of entry as a therapeutic for hepatitis B and D"
A recording will be posted here shortly.
Oct. 1 - Nicholas van Buuren, Ph.D., Gilead Sciences
"Integrated HBV DNA: Investigation of the Architecture and Potential Clinical Implications."
A recording is posted here.
Sept. 13 - Rudolf K. Beran, Ph.D., Gilead Sciences
“Characterizing the interplay between hepatitis B virus X protein and Smc5/6."
A recording is posted here.
Aug. 13 - V. Narry Kim, M.S., D.Phil, Professor, Seoul National University
"Viral hijacking of host functions to protect viral RNA"
A recording is posted here.
July 16 - Andrew Vaillant, Ph.D., Chief Scientific Officer, Replicor Inc.
"Understanding HBsAg and subviral particles: key players in chronic HBV infection and key targets in achieving functional cure of HBV."
A recording is posted here.
June 30 - Marion Peters, M.D., University of California, San Francisco
Bruce Witte Distinguished Lecture, "Precision Medicine for Chronic Hepatitis B"
A recording is posted here.
June 18 - Scott L. Friedman, M.D., Icahn School of Medicine, N.Y.C.
"Mechanisms of Fibrosis Development in NAFLD and Therapeutic Strategies"
A recording is posted here.
June 4 - Mala Maini, M.D., University College, London
"Immunobiology of Chronic Hepatitis B"
A recording is posted here: